Clinical trial
Real-World, Long-Term Data Collection to Gain Clinical Insights Into Faricimab (FaReal Study)
NCT06680817 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real-World, Long-Term Data Collection to Gain Clinical Insights Into Faricimab (FaReal Study)
- Lead sponsor
- Hoffmann-La Roche
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- February 5, 2025
- Completion date
- June 30, 2028
- Enrollment
- 875 (estimated)
- Sites
- 59
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic macular edema, neovascular age-related macular degeneration